Lowering Barriers to Technology Adoption:
CMC helps researchers and industry across Canada’s National Design Network® develop innovations in microsystems and nanotechnologies.
Academic entrepreneur Hossein Kassiri (centre) developed an implantable device with micro-EEG capability
to actively detect and prevent epileptic seizures. His technology is now being commercialized through
Braincom, a startup company he created with business partner Nima Soltani (left).
Dr. Boris Stoeber (right), professor at University of British Columbia, is redefining drug delivery through the
development of painless, hollow metal microneedle arrays that barely penetrate the skin. More recently,
he and his team have integrated optical sensing properties into these arrays, offering a faster, cheaper and
less invasive alternative to hypodermic-based blood sampling for drug monitoring. Founder of microneedle
startup Microdermics, he is shown here with company co-founder Iman Mansoor (centre) and Dr. Mehrsa
Raeiszadeh (left), Microdermics employee.
University of Waterloo innovator Karim Karim (far right) and his team combined existing LCD technology
and manufacturing processes with a unique electronic architecture to create better, safer and lower-cost
X-ray imaging. Their technology offers the potential to improve disease screening and diagnosis worldwide,
especially in remote and underserved communities.